ATTR clinical trials at UCLA
1 research study open to eligible people
Showing trials for
Patients With Transthyretin (ATTR) Amyloidosis
open to eligible people ages 18-130
The MaesTTRo study aims to enroll a global cohort of patients with transthyretin (ATTR) amyloidosis to longitudinally observe the natural course of the disease and describe real-world treatment patterns and outcomes. In addition, information on the…
Los Angeles, California and other locations
Last updated: